New pill aims to tame rheumatoid arthritis pain

NCT ID NCT07408024

First seen Feb 15, 2026 · Last updated May 16, 2026 · Updated 15 times

Summary

This study tests a new oral drug, TollB-001, in 24 adults aged 18-70 with moderate to severe active rheumatoid arthritis who haven't responded well to standard treatments. Participants take the drug or a placebo daily for 4 weeks, with a 1-week follow-up. The goal is to check safety and see if it improves symptoms like joint pain and swelling.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Inner Mongolia Medical University

    RECRUITING

    Hohhot, Inner Mongolia, China

    Contact Phone: •••-•••-••••

  • Linfen Central Hospital

    RECRUITING

    Linfen, Shanxi, China

    Contact Phone: •••-•••-••••

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    RECRUITING

    Beijing, Beijing Municipality, 102206, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Pingxiang People's Hospital

    RECRUITING

    Pingxiang, Jiangxi, China

    Contact Phone: •••-•••-••••

  • Puyang Oilfield General Hospital

    RECRUITING

    Puyang, Henan, China

    Contact Phone: •••-•••-••••

  • The First Affiliated Hospital of Bengbu Medical College

    RECRUITING

    Bengbu, Anhui, China

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.